Medical Cannabis and Mental Health: New NICE Guidance Expected
NICE is expected to release updated guidance on medical cannabis for mental health conditions including PTSD, anxiety, and depression, following a comprehensive evidence review.
The National Institute for Health and Care Excellence is preparing to release revised clinical guidance covering the use of cannabis-based medicinal products in the management of mental health conditions. The review, which covers PTSD, generalised anxiety disorder, social anxiety disorder, and treatment-resistant depression, is expected to clarify prescribing standards and eligibility criteria for these patient groups.
Why Updated Guidance Is Needed
Since medical cannabis was made available on prescription in 2018, the evidence base has grown substantially. Observational data from the UK's patient registries, combined with findings from international clinical trials, now provides a more comprehensive picture of the potential therapeutic role of CBMPs in mental health care.
The current guidance is widely regarded as outdated, having been largely based on evidence available at the time of legalisation. The new review is expected to incorporate more recent randomised controlled trial data and to provide clearer direction for prescribers who have operated in a grey area when recommending CBMPs for mental health indications.
Conditions Under Review
- Post-traumatic stress disorder (PTSD) — significant observational evidence supports beneficial effects on intrusive symptoms and sleep
- Generalised anxiety disorder — recent UK and international trials show promising CBD outcomes
- Social anxiety disorder — small but methodologically robust studies support CBD's anxiolytic properties
- Treatment-resistant depression — limited but emerging evidence for THC-dominant formulations in refractory cases
What Patients Should Expect
Updated NICE guidance will not automatically result in NHS reimbursement for mental health indications. However, clearer prescribing criteria would be expected to increase the confidence of specialist prescribers and could result in growing numbers of eligible patients being offered cannabis-based medicines through private clinics.
Patients with mental health conditions seeking information about their options can read about the specific conditions covered on LeafMe. Visit our clinics directory to find a service with expertise in psychiatric presentations.
The Broader Picture
Mental health conditions represent one of the largest patient cohorts seeking medical cannabis in the UK. Better guidance in this area could significantly increase the appropriateness and consistency of prescribing and may ultimately support the case for NHS access for eligible patients.
